NCT04039646

Brief Summary

Perforated peptic ulcer (PPU) is a frequent emergency condition worldwide with associated mortality up to 30%. Open procedures have in the most part been replaced by laparoscopic techniques. The standard postoperative management of PPUD patients is predominantly based on traditional practices. The aim of this randomized controlled clinical trial was to investigate the feasibility of enhanced postoperative recovery pathways in patients who underwent laparoscopic repair for Perforated peptic ulcer.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2019

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

July 28, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 31, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
Last Updated

February 8, 2021

Status Verified

February 1, 2021

Enrollment Period

2.5 years

First QC Date

July 28, 2019

Last Update Submit

February 4, 2021

Conditions

Keywords

Perforated peptic ulcerEnhanced recovery after surgeryLaparoscopic repairComplications

Outcome Measures

Primary Outcomes (1)

  • Hospital stay

    The time patients stay in hospital.

    30 days

Study Arms (2)

Standard postoperative care group

ACTIVE COMPARATOR

Patients received standard postoperative care as ususal.

Combination Product: ERAS treatment

ERAS group

EXPERIMENTAL

Patients received postoperative ERAS treatment.

Combination Product: ERAS treatment

Interventions

ERAS treatmentCOMBINATION_PRODUCT

The ERAS group had an enhanced postoperative recovery protocol. The gastric content was aspirated via the nasogastric tube by the anesthesiologist at the end of the procedure, and the nasogastric tube was withdrawn in the operating room immediately after the patient had recovered from anesthesia. and also early feeding and move.

ERAS groupStandard postoperative care group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Perforated ulcer less than 10 mm in size
  • Patients received laprascopic repair

You may not qualify if:

  • \. refusal to join the study or sign the informed consent form 3. age younger than 18 years 3.the presence of any psychiatric or neurologic disease 4. class 3 and 4 surgical patients according to the classification of The American Society of Anesthesiologists 5. septic shock on admission 6. pregnancy 7. multiple perforated peptic ulcers 8. spontaneously sealed-off perforated ulcers that were diagnosed either preoperatively or during surgery and that did not require surgical repair 9.conversion to open technique 10. perforated ulcers that were not amenable to Graham patch repair because of size or technical considerations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Chaoyang Hospital, Capital Medical University

Beijing, Beijing Municipality, 100020, China

RECRUITING

MeSH Terms

Conditions

Peptic Ulcer Perforation

Condition Hierarchy (Ancestors)

Peptic UlcerDuodenal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesStomach Diseases

Study Officials

  • Li Hua Tian

    Ethics center, Beijing Chaoyang Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jia Gang Han, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chairman of General Surgery

Study Record Dates

First Submitted

July 28, 2019

First Posted

July 31, 2019

Study Start

July 1, 2019

Primary Completion

December 31, 2021

Study Completion

March 31, 2022

Last Updated

February 8, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations